nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ACE—focal segmental glomerulosclerosis	0.839	1	CbGaD
Cilazapril—ACE—arteriole—focal segmental glomerulosclerosis	0.0316	0.407	CbGeAlD
Cilazapril—ACE—nephron—focal segmental glomerulosclerosis	0.0138	0.177	CbGeAlD
Cilazapril—ACE—endothelium—focal segmental glomerulosclerosis	0.00648	0.0835	CbGeAlD
Cilazapril—SLC15A1—nephron tubule—focal segmental glomerulosclerosis	0.00414	0.0533	CbGeAlD
Cilazapril—SLC15A1—kidney—focal segmental glomerulosclerosis	0.00364	0.0469	CbGeAlD
Cilazapril—ACE—nephron tubule—focal segmental glomerulosclerosis	0.00297	0.0382	CbGeAlD
Cilazapril—Thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.0394	CcSEcCtD
Cilazapril—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0029	0.0388	CcSEcCtD
Cilazapril—ACE—kidney—focal segmental glomerulosclerosis	0.00261	0.0336	CbGeAlD
Cilazapril—Azotaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.0346	CcSEcCtD
Cilazapril—SLC15A2—nephron tubule—focal segmental glomerulosclerosis	0.00259	0.0333	CbGeAlD
Cilazapril—ACE—cortex of kidney—focal segmental glomerulosclerosis	0.00254	0.0327	CbGeAlD
Cilazapril—SLC15A2—kidney—focal segmental glomerulosclerosis	0.00228	0.0293	CbGeAlD
Cilazapril—SLC15A2—cortex of kidney—focal segmental glomerulosclerosis	0.00222	0.0285	CbGeAlD
Cilazapril—Digestion impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.0276	CcSEcCtD
Cilazapril—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.0226	CcSEcCtD
Cilazapril—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.0204	CcSEcCtD
Cilazapril—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.0198	CcSEcCtD
Cilazapril—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.0181	CcSEcCtD
Cilazapril—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.017	CcSEcCtD
Cilazapril—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0167	CcSEcCtD
Cilazapril—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.0161	CcSEcCtD
Cilazapril—Fosinopril—ACE—focal segmental glomerulosclerosis	0.00117	0.133	CrCbGaD
Cilazapril—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0153	CcSEcCtD
Cilazapril—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0153	CcSEcCtD
Cilazapril—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.015	CcSEcCtD
Cilazapril—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0144	CcSEcCtD
Cilazapril—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0143	CcSEcCtD
Cilazapril—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0142	CcSEcCtD
Cilazapril—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.0141	CcSEcCtD
Cilazapril—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.00105	0.0135	CbGeAlD
Cilazapril—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0139	CcSEcCtD
Cilazapril—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0137	CcSEcCtD
Cilazapril—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.000995	0.0133	CcSEcCtD
Cilazapril—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000987	0.0132	CcSEcCtD
Cilazapril—Perindopril—ACE—focal segmental glomerulosclerosis	0.000954	0.108	CrCbGaD
Cilazapril—Spirapril—ACE—focal segmental glomerulosclerosis	0.000944	0.107	CrCbGaD
Cilazapril—ABCB1—kidney—focal segmental glomerulosclerosis	0.000919	0.0118	CbGeAlD
Cilazapril—Moexipril—ACE—focal segmental glomerulosclerosis	0.000905	0.103	CrCbGaD
Cilazapril—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000895	0.0115	CbGeAlD
Cilazapril—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000852	0.0114	CcSEcCtD
Cilazapril—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00085	0.0114	CcSEcCtD
Cilazapril—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000844	0.0113	CcSEcCtD
Cilazapril—Quinapril—ACE—focal segmental glomerulosclerosis	0.000841	0.0955	CrCbGaD
Cilazapril—Lisinopril—ACE—focal segmental glomerulosclerosis	0.000841	0.0955	CrCbGaD
Cilazapril—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000833	0.0111	CcSEcCtD
Cilazapril—Ramipril—ACE—focal segmental glomerulosclerosis	0.000814	0.0925	CrCbGaD
Cilazapril—Trandolapril—ACE—focal segmental glomerulosclerosis	0.000814	0.0925	CrCbGaD
Cilazapril—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00081	0.0108	CcSEcCtD
Cilazapril—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000801	0.0107	CcSEcCtD
Cilazapril—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000782	0.0104	CcSEcCtD
Cilazapril—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000762	0.0102	CcSEcCtD
Cilazapril—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00076	0.0101	CcSEcCtD
Cilazapril—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000757	0.0101	CcSEcCtD
Cilazapril—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000751	0.01	CcSEcCtD
Cilazapril—Benazepril—ACE—focal segmental glomerulosclerosis	0.000732	0.0831	CrCbGaD
Cilazapril—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000731	0.00976	CcSEcCtD
Cilazapril—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000729	0.00974	CcSEcCtD
Cilazapril—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000725	0.00969	CcSEcCtD
Cilazapril—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000695	0.00929	CcSEcCtD
Cilazapril—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00069	0.00922	CcSEcCtD
Cilazapril—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000688	0.0092	CcSEcCtD
Cilazapril—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000685	0.00915	CcSEcCtD
Cilazapril—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00068	0.00909	CcSEcCtD
Cilazapril—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000668	0.00893	CcSEcCtD
Cilazapril—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000647	0.00864	CcSEcCtD
Cilazapril—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000644	0.0086	CcSEcCtD
Cilazapril—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000629	0.00841	CcSEcCtD
Cilazapril—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000622	0.00832	CcSEcCtD
Cilazapril—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00062	0.00828	CcSEcCtD
Cilazapril—Enalapril—ACE—focal segmental glomerulosclerosis	0.000617	0.0701	CrCbGaD
Cilazapril—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000613	0.00819	CcSEcCtD
Cilazapril—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000595	0.00795	CcSEcCtD
Cilazapril—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000593	0.00792	CcSEcCtD
Cilazapril—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000591	0.0079	CcSEcCtD
Cilazapril—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000586	0.00784	CcSEcCtD
Cilazapril—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000581	0.00776	CcSEcCtD
Cilazapril—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000566	0.00756	CcSEcCtD
Cilazapril—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00056	0.00749	CcSEcCtD
Cilazapril—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000558	0.00746	CcSEcCtD
Cilazapril—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000552	0.00737	CcSEcCtD
Cilazapril—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000545	0.00728	CcSEcCtD
Cilazapril—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000542	0.00725	CcSEcCtD
Cilazapril—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00054	0.00722	CcSEcCtD
Cilazapril—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000527	0.00704	CcSEcCtD
Cilazapril—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000521	0.00697	CcSEcCtD
Cilazapril—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000514	0.00687	CcSEcCtD
Cilazapril—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000514	0.00687	CcSEcCtD
Cilazapril—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000514	0.00687	CcSEcCtD
Cilazapril—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000512	0.00685	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000511	0.00682	CcSEcCtD
Cilazapril—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000508	0.00679	CcSEcCtD
Cilazapril—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000503	0.00672	CcSEcCtD
Cilazapril—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000497	0.00664	CcSEcCtD
Cilazapril—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000493	0.00659	CcSEcCtD
Cilazapril—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000482	0.00645	CcSEcCtD
Cilazapril—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000479	0.0064	CcSEcCtD
Cilazapril—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000476	0.00637	CcSEcCtD
Cilazapril—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00047	0.00628	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000449	0.006	CcSEcCtD
Cilazapril—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000446	0.00596	CcSEcCtD
Cilazapril—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000442	0.00591	CcSEcCtD
Cilazapril—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000439	0.00587	CcSEcCtD
Cilazapril—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000438	0.00585	CcSEcCtD
Cilazapril—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000434	0.0058	CcSEcCtD
Cilazapril—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000428	0.00572	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000425	0.00569	CcSEcCtD
Cilazapril—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000425	0.00568	CcSEcCtD
Cilazapril—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000421	0.00563	CcSEcCtD
Cilazapril—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000421	0.00563	CcSEcCtD
Cilazapril—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000406	0.00543	CcSEcCtD
Cilazapril—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000403	0.00538	CcSEcCtD
Cilazapril—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000391	0.00523	CcSEcCtD
Cilazapril—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00039	0.00521	CcSEcCtD
Cilazapril—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000363	0.00485	CcSEcCtD
Cilazapril—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000354	0.00472	CcSEcCtD
Cilazapril—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000349	0.00466	CcSEcCtD
Cilazapril—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000337	0.00451	CcSEcCtD
Cilazapril—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000326	0.00435	CcSEcCtD
Cilazapril—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000313	0.00419	CcSEcCtD
Cilazapril—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000311	0.00415	CcSEcCtD
Cilazapril—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00031	0.00415	CcSEcCtD
Cilazapril—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000309	0.00413	CcSEcCtD
Cilazapril—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000293	0.00391	CcSEcCtD
Cilazapril—Nateglinide—ALB—focal segmental glomerulosclerosis	0.000173	0.0196	CrCbGaD
